1. Decoy Exosomes Offer Protection Against Chemotherapy-Induced Toxicity.
- Author
-
Fan M, Li H, Shen D, Wang Z, Liu H, Zhu D, Wang Z, Li L, Popowski KD, Ou C, Zhang K, Zhang J, Cheng K, and Li Z
- Subjects
- Humans, Cardiotoxicity etiology, Cardiotoxicity prevention & control, Cardiotoxicity metabolism, Quality of Life, Exosomes genetics, Exosomes metabolism, Neoplasms, Antineoplastic Agents toxicity, Antineoplastic Agents metabolism, Chemical and Drug Induced Liver Injury metabolism
- Abstract
Cancer patients often face severe organ toxicity caused by chemotherapy. Among these, chemotherapy-induced hepatotoxicity and cardiotoxicity are the main causes of death of cancer patients. Chemotherapy-induced cardiotoxicity even creates a new discipline termed "cardio-oncology". Therefore, relieving toxicities induced by chemotherapy has become a key issue for improving the survival and quality of life in cancer patients. In this work, mesenchymal stem cell exosomes with the "G-C" abundant tetrahedral DNA nanostructure (TDN) are modified to form a decoy exosome (Exo-TDN). Exo-TDN reduces DOX-induced hepatotoxicity as the "G-C" base pairs scavenge DOX. Furthermore, Exo-TDN with cardiomyopathic peptide (Exo-TDN-PCM) is engineered for specific targeting to cardiomyocytes. Injection of Exo-TDN-PCM significantly reduces DOX-induced cardiotoxicity. Interestingly, Exo-TDN-PCM can also promote macrophage polarization into the M2 type for tissue repair. In addition, those decoy exosomes do not affect the anticancer effects of DOX. This decoy exosome strategy serves as a promising therapy to reduce chemo-induced toxicity., (© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.)
- Published
- 2022
- Full Text
- View/download PDF